JOHANNESSEN JAN 4

What Happened
Jan Johannessen, a non-employee director of Twist Bioscience (TWST), was granted 5,095 restricted stock units (RSUs) on 2026-02-05 (award reported as $0 cash paid) and on 2026-02-06 sold 2,200 shares in an open-market transaction at $47.91 per share, generating $105,395. The sale was a tax withholding "sell to cover" tied to the RSU vesting, not a discretionary sell.

Key Details

• Grant: 5,095 RSUs on 2026-02-05 (transaction code A); no cash paid at grant (reported $0.00).
• Sale: 2,200 shares on 2026-02-06 at $47.91/share, proceeds $105,395 (transaction code S).
• Shares owned after transaction: not specified in the provided filing.
• Footnote F1: 100% of the annual award vests on the earlier of the one-year anniversary of grant or the first annual meeting after grant, provided the director remains a service provider.
• Footnote F2: The 2,200-share sale was a pre-elected sell-to-cover to satisfy tax withholding related to RSU vesting and is not a discretionary trade by the reporting person.
• Filing: Form 4 filed 2026-02-09 (covers 2026-02-05/02-06 transactions); filing appears timely under the two-business-day rule.

Context
RSU grants to non-employee directors are common compensation; the award itself is not a market purchase and will vest per the schedule in F1. The sell-to-cover is a routine tax-withholding action (F2) and should not be interpreted as an independent sell signal from the director.